You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABBV Sale Disclosure
Stewart Jeffrey Ryan · SEC Form 4 · Filed Nov 12, 2026
Sale
Calculated transaction value
$11.93M
Stewart Jeffrey Ryan EVP, Chief Commercial Officer
ABBV
ABBVIE INC
ABBV
Transaction date
Nov 9, 2026
Public filing date
Nov 12, 2026
Filing lag
Filed 3 days later
ABBV daily price context
Close on/before transaction
$293.3
Nov 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, $0.01 par value
- Quantity / price
- 40,619 shares @ $293.6
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001761675-26-000007
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$16.06M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Abbvie Inc. ABBV | Gift | Nov 12, 2026 | $0 |
| Abbvie Inc. ABBV | Exercise | Nov 9, 2026 | $0 |
| Abbvie Inc. ABBV | Exercise | Nov 9, 2026 | $0 |
| Abbvie Inc. ABBV | Exercise | Nov 9, 2026 | $1.84M |
| Abbvie Inc. ABBV | Exercise | Nov 9, 2026 | $2.3M |
| Abbvie Inc. ABBV Current | Sale | Nov 9, 2026 | $11.93M |